Author

Martin Pehrsson

A MARKER OF PROTEOLYTIC DEGRADATION OF CROSS-LINKED TYPE V COLLAGEN IS UPREGULATED IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
A MARKER OF PROTEOLYTIC DEGRADATION OF CROSS-LINKED TYPE V COLLAGEN IS UPREGULATED IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

A NEO-EPITOPE SPECIFIC BIOMARKER OF FIBROSIS RESOLUTION - DETECTION OF PROTEASE DEGRADED, AND CROSS-LINKED TYPE III COLLAGEN DEGRADATION METABOLITES RELEASED WITH FIBROLYSIS
A NEO-EPITOPE SPECIFIC BIOMARKER OF FIBROSIS RESOLUTION - DETECTION OF PROTEASE DEGRADED, AND CROSS-LINKED TYPE III COLLAGEN DEGRADATION METABOLITES RELEASED WITH FIBROLYSIS

A NEO-EPITOPE SPECIFIC BIOMARKER OF FIBROSIS RESOLUTION - DETECTION OF PROTEASE DEGRADED, AND CROSS-LINKED TYPE III COLLAGEN DEGRADATION METABOLITES RELEASED WITH FIBROLYSIS
A NEO-EPITOPE SPECIFIC BIOMARKER OF FIBROSIS RESOLUTION - DETECTION OF PROTEASE DEGRADED, AND CROSS-LINKED TYPE III COLLAGEN DEGRADATION METABOLITES RELEASED WITH FIBROLYSIS

Martin Pehrsson  et al.

NOVEL SEROLOGICAL BIOMARKERS FOR MONITORING DISEASE PROGRESSION IN ADULT EOSINOPHILIC ESOPHAGITIS PATIENTS
NOVEL SEROLOGICAL BIOMARKERS FOR MONITORING DISEASE PROGRESSION IN ADULT EOSINOPHILIC ESOPHAGITIS PATIENTS

Martin Pehrsson

PROTEIN FINGERPRINT BIOMARKERS OF COLLAGEN REMODELING CAN EVALUATE FIBROGENESIS IN AN IN VITRO COLONIC SCAR-IN-A-JAR MODEL
PROTEIN FINGERPRINT BIOMARKERS OF COLLAGEN REMODELING CAN EVALUATE FIBROGENESIS IN AN IN VITRO COLONIC SCAR-IN-A-JAR MODEL

Martin Pehrsson  et al.

NOVEL SEROLOGICAL BIOMARKERS FOR MONITORING DISEASE PROGRESSION IN ADULT EOSINOPHILIC ESOPHAGITIS PATIENTS
NOVEL SEROLOGICAL BIOMARKERS FOR MONITORING DISEASE PROGRESSION IN ADULT EOSINOPHILIC ESOPHAGITIS PATIENTS

Martin Pehrsson  et al.

NON-INVASIVE BIOMARKERS OF TYPE III COLLAGEN CROSS-LINKING REFLECT FIBROLYSIS IN CROHN'S DISEASE PATIENTS WITH A NON-STRICTURING AND NON-PENETRATING DISEASE BEHAVIOUR
NON-INVASIVE BIOMARKERS OF TYPE III COLLAGEN CROSS-LINKING REFLECT FIBROLYSIS IN CROHN'S DISEASE PATIENTS WITH A NON-STRICTURING AND NON-PENETRATING DISEASE BEHAVIOUR

Martin Pehrsson  et al.

BIOMARKERS OF ELASTIN DEGRADATION DIFFERENTIATE BETWEEN CLINICALLY INACTIVE AND ACTIVE DISEASE IN UC PATIENTS
BIOMARKERS OF ELASTIN DEGRADATION DIFFERENTIATE BETWEEN CLINICALLY INACTIVE AND ACTIVE DISEASE IN UC PATIENTS

Martin Pehrsson  et al.

A MARKER OF PROTEOLYTIC DEGRADATION OF CROSS-LINKED TYPE V COLLAGEN IS UPREGULATED IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
A MARKER OF PROTEOLYTIC DEGRADATION OF CROSS-LINKED TYPE V COLLAGEN IS UPREGULATED IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

Martin Pehrsson  et al.

BIOMARKERS OF ELASTIN DEGRADATION IS ASSOCIATED WITH CLINICAL AND BIOCHEMICALLY ACTIVE DISEASE IN CROHN'S DISEASE
BIOMARKERS OF ELASTIN DEGRADATION IS ASSOCIATED WITH CLINICAL AND BIOCHEMICALLY ACTIVE DISEASE IN CROHN'S DISEASE

Martin Pehrsson  et al.

NON-INVASIVE BIOMARKERS OF TYPE III COLLAGEN CROSS-LINKING REFLECT FIBROLYSIS IN CROHN'S DISEASE PATIENTS WITH A NON-STRICTURING AND NON-PENETRATING DISEASE BEHAVIOUR
NON-INVASIVE BIOMARKERS OF TYPE III COLLAGEN CROSS-LINKING REFLECT FIBROLYSIS IN CROHN'S DISEASE PATIENTS WITH A NON-STRICTURING AND NON-PENETRATING DISEASE BEHAVIOUR

NOVEL SEROLOGICAL BIOMARKERS FOR MONITORING DISEASE PROGRESSION IN ADULT EOSINOPHILIC ESOPHAGITIS PATIENTS
NOVEL SEROLOGICAL BIOMARKERS FOR MONITORING DISEASE PROGRESSION IN ADULT EOSINOPHILIC ESOPHAGITIS PATIENTS

Martin Pehrsson  et al.

A BIOMARKER OF EARLY MUCOSAL DESTRUCTION: NEUTROPHIL-MEDIATED TYPE IV COLLAGEN DEGRADATION IS ELEVATED IN PATIENTS WITH CROHN’S DISEASE AND ULCERATIVE COLITIS
A BIOMARKER OF EARLY MUCOSAL DESTRUCTION: NEUTROPHIL-MEDIATED TYPE IV COLLAGEN DEGRADATION IS ELEVATED IN PATIENTS WITH CROHN’S DISEASE AND ULCERATIVE COLITIS

Martin Pehrsson  et al.

ENDOTROPHIN (PRO-C6) IS ASSOCIATED WITH MRE CONFIRMED INTESTINAL STRICTURES AND PROTEIN FINGERPRINT BIOMARKERS OF COLLAGEN DEGRADATION IS ASSOCIATED WITH ULCERATIONS IN PAEDIATRIC CROHN’S DISEASE PATIENTS – RESULTS FROM THE IMAGEKIDS STUDY
ENDOTROPHIN (PRO-C6) IS ASSOCIATED WITH MRE CONFIRMED INTESTINAL STRICTURES AND PROTEIN FINGERPRINT BIOMARKERS OF COLLAGEN DEGRADATION IS ASSOCIATED WITH ULCERATIONS IN PAEDIATRIC CROHN’S DISEASE PATIENTS – RESULTS FROM THE IMAGEKIDS STUDY

Martin Pehrsson  et al.

PROTEIN FINGERPRINT ASSAYS REFLECTING NEUTROPHIL ACTIVITY, MUCOSAL DAMAGE, AND TISSUE FIBROSIS ARE SURROGATE BIOMARKERS FOR MUCOSAL HEALING IN PEDIATRIC CROHN’S DISEASE
PROTEIN FINGERPRINT ASSAYS REFLECTING NEUTROPHIL ACTIVITY, MUCOSAL DAMAGE, AND TISSUE FIBROSIS ARE SURROGATE BIOMARKERS FOR MUCOSAL HEALING IN PEDIATRIC CROHN’S DISEASE

Martin Pehrsson  et al.

TYPE I COLLAGEN DEGRADATION FRAGMENTS (C1M) AND HUMAN NEUTROPHIL ELASTASE-DERIVED FRAGMENTS OF CALPROTECTIN (CPA9-HNE) REFLECT BIOCHEMICAL AND ENDOSCOPIC DISEASE ACTIVITY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES
TYPE I COLLAGEN DEGRADATION FRAGMENTS (C1M) AND HUMAN NEUTROPHIL ELASTASE-DERIVED FRAGMENTS OF CALPROTECTIN (CPA9-HNE) REFLECT BIOCHEMICAL AND ENDOSCOPIC DISEASE ACTIVITY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES

Martin Pehrsson  et al.

BIOMARKERS OF EXTRACELLULAR MATRIX TURNOVER AND NEUTROPHIL ACTIVITY PREDICT LONG-TERM RESPONSE TO VEDOLIZUMAB IN PATIENTS WITH CROHN’S DISEASE
BIOMARKERS OF EXTRACELLULAR MATRIX TURNOVER AND NEUTROPHIL ACTIVITY PREDICT LONG-TERM RESPONSE TO VEDOLIZUMAB IN PATIENTS WITH CROHN’S DISEASE

Martin Pehrsson  et al.

SEROLOGICAL BIOMARKERS OF TYPE I, III, AND IV COLLAGEN TURNOVER ARE ASSOCIATED WITH THE PRESENCE AND FUTURE PROGRESSION OF STRICTURING AND PENETRATING CROHN'S DISEASE
SEROLOGICAL BIOMARKERS OF TYPE I, III, AND IV COLLAGEN TURNOVER ARE ASSOCIATED WITH THE PRESENCE AND FUTURE PROGRESSION OF STRICTURING AND PENETRATING CROHN'S DISEASE

Martin Pehrsson  et al.

Item 1 - 18 / 18
1